Is this the last chance to snap up Barclays shares at a bargain price?

The Barclays share price has motored higher this year, but Roland Head thinks further gains are likely. He explains why the shares look cheap.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Bearded man writing on notepad in front of computer

Image source: Getty Images

Will 2023 be the year that the Barclays (LSE: BARC) share price finally starts to deliver results for long-suffering shareholders? I think it could be.

The FTSE 100 bank’s profits held up well during the pandemic, when market conditions favoured its investment banking division. Now, rising interest rates are expected to improve the profitability of the group’s high street bank as lending rates rise.

Still cheap despite gains

Barclays shares have performed well already this year. They’re up by 40% from their October lows.

However, at 190p, the bank’s stock is still trading at a 30% discount to its book value of 286p per share. I think that gap could start to close this year.

I reckon that the key to a higher valuation is for the bank to show consistent profitability. Recent progress seems encouraging to me.

In 2021, Barclays generated a return on tangible equity of 13.4%. During the first nine months of 2022, that figure was 12.5%.

If the firm’s 2022 results — due next week — show a similar performance for the whole of 2022, I think the shares could continue to rise.

Recession worries

Rising interest rates have been good for banks, so far. But this might not continue.

If the UK economy falls into recession, then Barclays could see higher rates of bad debt on mortgages and loans. Credit card arrears at Barclaycard could also rise sharply.

Another risk is that the business could come under pressure to pass on higher interest rates to savers. While big lenders have been quick to increase mortgage rates over the last six months, they’ve been much slower to increase interest rates on savings accounts.

CEOs from the big banks were quizzed about this issue by MPs recently. I’ve already switched my savings account away from a big bank to a smaller lender. I’m now getting 3% interest instead of just 0.6%. I suspect more people will do this unless the banks start to play fair.

My verdict

Current broker forecasts value Barclays shares on a 2023 price-to-earnings (P/E) ratio of six. That’s cheaper than rivals NatWest and Lloyds. In fact, the stock seems cheap to me by any measure, given Barclays’ improved profitability and strong finances.

I think we could see the stock re-rate to a higher P/E ratio this year. One catalyst for this could be the dividend. City analysts expect the shareholder payout to rise by around 20% annually over the next couple of years.

Those numbers give Barclays a 2023 forecast dividend yield of 4.7%, rising to 5.6% in 2024. That looks attractive to me.

Although bank stocks have been disappointing investments since 2008, I think we’re finally seeing a return to normality. In my view, Barclays shares look very cheap at current levels. I reckon they could be a profitable buy.

Roland Head has positions in NatWest Group Plc. The Motley Fool UK has recommended Barclays Plc and Lloyds Banking Group Plc. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Middle-aged white man pulling an aggrieved face while looking at a screen
Market Movers

Down 7%! Why on earth are Imperial Brands shares plummeting today?

Imperial Brands shares are in freefall after a negative reception to fresh trading news. Is the party finally over for…

Read more »

Rear View Of Woman Holding Man Hand during travel in cappadocia
Investing Articles

With a P/E under 7, this value stock looks far too cheap at 101p

This writer reckons value stock Hostelworld (LSE:HSW) looks dirt-cheap as it gets dividends flowing again and builds a social travel…

Read more »

Thoughtful man using his phone while riding on a train and looking through the window
Investing For Beginners

Down 30% in 6 months, I think there’s a big catch to this insanely cheap stock

Jon Smith talks through why careful research is needed when trying to assess if a cheap stock is worth buying…

Read more »

Investing Articles

£5,000 invested in National Grid shares 5 years ago is now worth…

Andrew Mackie takes a closer look at National Grid shares and why short-term market weakness could be missing a powerful…

Read more »

DIVIDEND YIELD text written on a notebook with chart
Investing Articles

How big does an ISA need to be to aim for a £1,500 monthly second income?

Harvey Jones shows how building a balanced portfolio of FTSE 100 dividend stocks can produce a high-and-rising second income in…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

£20,000 invested in BP shares 1 year ago is now worth…

BP shares have rocketed in the past 12 months, yet analysts think the real growth story is only just beginning,…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

A 6.8% forecast yield! 1 often-overlooked FTSE 100 income stock to buy today?

This income stock offers a high forecast yield and strengthening momentum, yet many investors overlook it — creating a rare…

Read more »

GSK scientist holding lab syringe
Investing Articles

GSK’s share price is under £22, but with a ‘fair value’ much higher, is it time for me to buy more right now? 

GSK’s share price rose over the last year, but a huge gap remains between its price and fair value —…

Read more »